Nectar Lifesciences Ltd

Nectar Lifesciences Ltd

Nectar Lifesciences Ltd has announced the closure of its trading window for designated persons and their immediate relatives from October 1, 2026, till 48 hours after the declaration of Financial Results for the period ended on September 30, 2026, pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Nectar Lifesciences Ltd

Nectar Lifesciences Ltd has announced the 31st Annual General Meeting (AGM) scheduled for September 18, 2026, through video conference. The company has also made available the AGM Notice and Annual Report for the financial year 2025-26 on its website and on the websites of the stock exchanges where its equity shares are listed.

Nectar Lifesciences Ltd

Nectar Lifesciences Ltd has published a notice of its 31st Annual General Meeting, e-voting, book closure, and other information in newspapers as required by the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Nectar Lifesciences Ltd

Nectar Lifesciences Ltd has announced its 31st Annual General Meeting (AGM) and Annual Report for the financial year ended March 31, 2026. The AGM will be held on September 18, 2026, through video conferencing, and will consider various resolutions, including the re-appointment of Dr. Indu Pal Kaur as an Independent Director and the adoption of the standalone and consolidated financial statements.

Nectar Lifesciences Ltd

Nectar Lifesciences Ltd has announced the notice of its 31st Annual General Meeting (AGM) to be held on September 18, 2026, through video conferencing. The meeting will consider the standalone and consolidated financial statements for the year ended March 31, 2026, and the re-appointment of Dr. Indu Pal Kaur as an Independent Director for a second term.

Nectar Lifesciences Ltd

Nectar Lifesciences Ltd has published a notice to shareholders regarding its 31st Annual General Meeting (AGM) to be held on September 18, 2026, through video conferencing. The notice was published in Business Standard and Desh Sewak newspapers on August 20, 2026.

Nectar Lifesciences Ltd

Nectar Lifesciences Ltd has published its unaudited financial results for the quarter ended June 30, 2026, showing a net profit of Rs. 716.58 lakhs and a total income from operations of Rs. 9,503.30 lakhs. The company has also announced its 32nd Annual General Meeting, to be held on September 23, 2026.

Nectar Lifesciences Ltd

Nectar Lifesciences Ltd has announced a change in its corporate office address from Plot No. 110, Industrial Area, Phase 1, Chandigarh 160 002 to "Godrej Eternia," West Wing (Tower A), Plot No. 70, Industrial Area, Phase-1, Chandigarh, 160 002, effective from September 15, 2026.

Nectar Lifesciences Ltd

Nectar Lifesciences Ltd has announced the book closure and cut-off date for its 31st Annual General Meeting (AGM) for the financial year 2025-26, to be held on September 18, 2026. The book closure will be from September 12, 2026, to September 18, 2026.

Nectar Lifesciences Ltd

Nectar Lifesciences Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and has also appointed Dr. Gunmala Suri as an Additional Director and reconstituted its Audit Committee, Stakeholders Relationship Committee, and Corporate Social Responsibility Committee.

Nectar Lifesciences Ltd

Nectar Lifesciences Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the appointment of a new director and reconstitution of committees.

Nectar Lifesciences Ltd

Nectar Lifesciences Ltd has scheduled a Board Meeting on August 14, 2026, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026, and other business matters.

Nectar Lifesciences Ltd

Nectar Lifesciences Ltd announced the resignation of Dr. Surulichamy Senthilkumar as a Non-Executive Non-Independent Director, effective August 6, 2026. The company has attached a letter from the director and provided details as required under LODR Regulations.

Nectar Lifesciences Ltd

Nectar Lifesciences Ltd has extended the expected completion date of the slump sale of its Empty Hard Gelatin Capsule business to on or before December 31, 2026, from the previously announced date.